CLINICAL / ANATOMIC PATHOLOGY / CRO LABORATORIES
Current Listings
Tech-2564: Clinical Laboratory in Midwest For Sale – Unique Revenue Model
CLIA, COLA, CAP-accredited clinical lab in Midwest for Sale. Unique Revenue Model, Consistent Revenue, Exceptional EBITDA Margins. Revenue: $3.4M, EBITDA: $1.4M
Tech-2558: Fairly New, Clinical Lab in NJ For Sale – Molecular and NGS Assays
This almost brand new NJ Lab is set up as a high throughput lab for Molecular, Covid, and NGS testing. Revenue (10 months): $2.1M, net $1.7M, Price: $2.75M.
UNDER LOI: Tech-2562: Brand New Clinical Lab For Sale (CO and CA Licenses)
Brand New Clinical Laboratory in CO For Sale. New equipment validated for Covid and PGx. CO and CA licenses. Price: $325K. Includes equipment and Inventory worth $500K.
Tech-2557: Fast-Growing Clinical Lab in TX For Sale
Profitable, fast-growing Lab in Texas. Mostly non-covid testing. Revenue / EBITDA: $5.7M/690K (2022); $8.2M/$1M+ (2023).
Tech-2538: Fairly New, Clinical Lab in Georgia
This Lab offers a solid platform for growth. A completely managed Lab that anyone with marketing and management skills can run. Price: $300K.
Tech-2524: Brand New Molecular CLIA Lab in the TN
Validated for Molecular Detection of Pathogens and Covid-19. Debt-free. Can optionally provide customization and complete management. $550K Asking Price.
Tech-2503: Very Profitable, Well-Established Clinical Lab in the South East
The lab has a diversified Revenue Stream from Toxicology, Women’s Health, UTI, Covid, and Respiratory Panel Testing. The lab is well-positioned to continue to grow post-Covid. 2021 Revenue: $6.8M, EBITDA: $2.6M.
Sold Clinical and Pathology Labs
SOLD: Tech-2534: Profitable NJ Lab with NY, NJ and PA Licenses
This turn-key lab comes with a great location, excellent growth potential with marketing, and hard-to-get licenses of NY, NJ, and PA in favorable MAC. Had Medicare, Medicaid, and Multiplan. Price $2.2 million
SOLD: Tech-2506: CRO in South East with Expertise in NGS, RNA, Genomics, Biomarker Services
SOLD: The CRO Lab is one of the Early Adapters in Next Generation Sequences and deep expertise in research and applications Biomarkers, Disease Diagnostics and Treatment Development, using RNA, mRNA and microRNA arrays.
SOLD: Tech-2440: Anatomic Pathology Lab in the North East
Very profitable, successful, and fast-growing anatomical lab in the North East. Known for its high level of service. Revenue; $4-5MM; EBITDA: $1.5-$2MM
SOLD: Tech-2466: Profitable Clinical Lab in Mountain States
SOLD: Profitable Clinical Lab in the Mountain States. Has important network contracts. Gross Revenue: $480K; SDE: $180K; Asking Price: $900K. Includes Aetna, BC, Cigna, Medicare.
SOLD – Tech-2472: NY / CLIA License of a Clinical Lab
SOLD: NY CLIA license. This Clinical lab does Endocrinology / Fertility testing and comes with clean CLIA and NY state licenses. The corporation is only two years old.
SOLD: Tech-2461: Turn-key, High-Capacity, Clinical and Toxicology Labs with two Clean CLIAs in Texas
A rare opportunity to acquire two adjacent CLIA labs - Both Labs have Licenses for 38 states. Comes with completely paid off newer equipment which were bought for $2.7M. Asking price $1.1M. Includes,...
SOLD: Tech-2243: DNA Paternity Testing, Forensic Testing Lab in South East
SOLD Tech-2243: DNA Paternity Testing, Forensic Testing Lab in South East. Gross Income (2012): $288K, Discretionary Cash Flow: $134K, assets: $125K.
SOLD: Tech-1510: Clinical Diagnostic Lab in Central Philadelphia
SOLD Tech-1510: Clinical Diagnostic Lab in Central Philadelphia. One Year Old, CLIA-Approved, Ideal Turn-key Business Opportunity for a Large Physician’s Group. Potential Annual Revenue and Net Profit: $3M and $1M.
SOLD: Tech-1503: Clia-Certified Profitable Clinical Lab with High Growth Potential in SE USA
SOLD: Tech-1503: CLIA-Certified Profitable Clinical Lab with High Growth Potential in SE USA. Revenue $1.9 million, EBITDA $264K, asset value ~688K.